Kyorin Holdings Inc
TSE:4569

Watchlist Manager
Kyorin Holdings Inc Logo
Kyorin Holdings Inc
TSE:4569
Watchlist
Price: 1 558 JPY -1.77% Market Closed
Market Cap: 89.5B JPY

Kyorin Holdings Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kyorin Holdings Inc
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Kyorin Holdings Inc
TSE:4569
Selling, General & Administrative
-ÂĄ44.8B
CAGR 3-Years
-8%
CAGR 5-Years
0%
CAGR 10-Years
1%
Takeda Pharmaceutical Co Ltd
TSE:4502
Selling, General & Administrative
-ÂĄ1.1T
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
-6%
Daiichi Sankyo Co Ltd
TSE:4568
Selling, General & Administrative
-ÂĄ722B
CAGR 3-Years
-26%
CAGR 5-Years
-20%
CAGR 10-Years
-5%
Otsuka Holdings Co Ltd
TSE:4578
Selling, General & Administrative
-ÂĄ958.3B
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
-4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Selling, General & Administrative
-ÂĄ110.1B
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
-2%
Astellas Pharma Inc
TSE:4503
Selling, General & Administrative
-ÂĄ825.2B
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
-7%

Kyorin Holdings Inc
Glance View

Market Cap
89.5B JPY
Industry
Pharmaceuticals

KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.

Intrinsic Value
2 099.37 JPY
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Kyorin Holdings Inc's Selling, General & Administrative?
Selling, General & Administrative
-44.8B JPY

Based on the financial report for Dec 31, 2024, Kyorin Holdings Inc's Selling, General & Administrative amounts to -44.8B JPY.

What is Kyorin Holdings Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
1%

Over the last year, the Selling, General & Administrative growth was -21%. The average annual Selling, General & Administrative growth rates for Kyorin Holdings Inc have been -8% over the past three years , and 1% over the past ten years .

Back to Top